DC CFAR investigators are highly active in local, national and international HIV/AIDS research.  Learn more about the latest research and funding news. 

New Investigator Publication from Manya Magnus, PhD, MPH and Irene Kuo, PhD, MPH

October 28, 2015

DC CFAR Investigators, Manya Magnus, PhD, MPH and Irene Kuo, PhD, MPH, along with other colleagues from the GW Milken Institute School of Public Health and the SUNY at Binghamton College of Community and Public Affairs recently published an article in Digital Culture & Education entitled, "Acceptability of a mobile smartphone application intervention to improve access to HIV prevention and care services for black men who have sex with men in the District of Columbia".

New Investigator Publication from Amanda Castel, MD, MPH

October 26, 2015

DC CFAR Investigators Amanda Castel, MD, MPH and James Peterson, EdD, along with Dr. Jennifer Skillicorn, DC CFAR Administrative Director, and colleagues from the GW Milken Institute School of Public Health and the DC Department of Health, publish article in PLoS One entitled "Comparing Cost-Effectiveness of HIV Testing Strategies: Targeted and Routine Testing in Washington, DC."

Social and Behavioral Sciences Core Call for Peer Group Consultation

October 22, 2015

The Social and Behavioral Sciences (SBS) Core is putting out a call for anyone interested in a peer group consultation in the months of November and/or December.

Patricio Ray, MD receives new R01 award, “Pathogenesis of Chronic Renal Injury and Hypertension in HIV-Infected Children.”

October 19, 2015

The DC CFAR would like to congratulate Patricio Ray, MD for his new R01 award, “Pathogenesis of Chronic Renal Injury and Hypertension in HIV-Infected Children.”

Impairment of ABCA1 glycosylation as a pathogenic mechanism in Nef-induced atherosclerosis

October 15, 2015

Radoslav Goldman, PhD has received an NIH CFAR Administrative supplement to characterize the role of glycosylation in ABCA1 functionality. ABCA1 is a key anti-atherogenic factor responsible for HDL production and cholesterol efflux. ABCA1 is targeted by HIV-1 Nef, which impairs ABCA1 maturation. Maturation of ABCA1 is tightly linked to its glycosylation, but detailed characterization of the role of glycosylation in ABCA1 functionality has not been done. Dr. Radoslav seeks to close this gap in our knowledge, providing the basis for future therapeutic efforts.

Advancing Pre-exposure Prophylaxis (PrEP) Delivery among Black MSM in the District of Columbia

October 13, 2015

Marc Siegel, MD has received an NIH CFAR Administrative supplement to study whether a novel culturally competent clinic intervention can increase the uptake of pre-exposure prophylaxis (PrEP) to prevent HIV infection in black and young men who have sex with men. This population are among the only US populations to have recently experienced a significant increase in the number of incident HIV infections.

DC CFAR Investigators, Natella Rakhmanina, MD and Kathleen Ferrer, MD, Featured in Washington Post

September 24, 2015

DC CFAR investigators Natella Rakhmanina, MD, Associate Professor of Pediatrics at the George Washington University and Clinic Director for the Special Immunology Service and Infectious Diseases at Children's National Medical Center, and Kathleen Ferrer, MD, Assistant Professor of Infectious Disease at Children's National Medical Center, were recently featured in an article in the Washington Post.

DC CFAR Investigator Featured in AJPH August Podcast

September 22, 2015

DC CFAR Investigator Maria Cecilia Zea, PhD has had her work featured in the American Journal of Public Health's August podcast. The podcast discusses her article published previously in the American Journal of Public Health, titled HIV Prevalence and Awareness of Positive Serostatus Among Men Who Have Sex With Men and Transgender Women in Bogota, Colombia.

New Investigator Publications from X. Simon Wang, PhD and Joseph Fortunak, PhD

September 21, 2015

DC CFAR investigator X Simon Wang, PhD, Associate Professor of Medicinal Chemistry in the Department of Pharmaceutical Sciences at the Howard University College of Pharmacy, has had two articles published in Combinatorial Chemistry & High Throughput Screening, and has also published a book chapter jointly with another DC CFAR investigator, Joseph Fortunak, PhD.

DC CFAR Community Advisory Board Pre-Conference Session

September 16, 2015

The DC CFAR Community Advisory Board (CAB) held a pre-conference panel session in association with the US Conference on AIDS (USCA).

DC CFAR Launch with Dr. Fauci

September 16, 2015

The DC CFAR held its official launch on September 15, 2015, featuring keynote speaker Anthony Fauci, MD from the National Institutes of Health.

New Publication features DC CFAR Investigators Xiong Jiang, PhD and Mary Young, MD

September 10, 2015

DC CFAR investigator Xiong Jiang, PhD, Assistant Professor in the Department of Neuroscience at Georgetown University, has had his work recently featured in Radiology Today, along with DC CFAR investigator Mary Young, MD, Assistant Professor at the Department of Medicine at Georgetown University and site Principal Investigator of the NIH funded Women's Intra-Agency HIV Study (WIHS).

Investigator Publications from Monica Ruiz, PhD

September 08, 2015

Monica Ruiz, PhD has received recent recognition for her work on the effect of needle exchange programs on HIV transmission in DC.

New Investigator Publication from Nina Yamanis, PhD

August 21, 2015

DC CFAR Investigator Thespina Yamanis, PhD, Assistant Professor at the School of International Service at American University, has just published an article in AIDS and Behavior entitled "Young Men's Social Network Characteristics and Associations with Sexual Partnership Concurrency in Tanzania".

New Publications from Dr. Nekhai, PhD and Dr. Amol Kulkarni, PhD

August 17, 2015

Sergei Nekhai, PhD, Co-Director of the DC CFAR Basic Sciences Core and Associate Professor of Medicine at Howard University, has co-authored two articles. One, published in Scientia Pharmaceutica, is titled "Activation of HIV-1 with Nanoparticle-Packaged Small-Molecule Protein Phosphatase-1-Targeting Compound". The other, co-authored by Amol Kulkarni, PhD, Associate Professor of Pharmaceutical Sciences at Howard University, was published in Drug Design, Development and Therapy. The article is titled "Inhibition of HIV-1 by curcumin A, a novel curcumin analog". These articles were funded in part by support from the DC CFAR.